Review finds no benefit to aspirin for preserving cognitive function

aspirin
Coated aspirin tablets. Image: Wikimedia Commons.

An analysis of published studies found no evidence that low- dose aspirin buffers against cognitive decline or dementia or improves cognitive test scores.

The review and meta-analysis included eight studies with 36,196 participants who were an average of 65 years old and did not have at baseline. Participants were followed for an average of six years.

"Additional studies are needed to test the possibility that low-dose aspirin has beneficial effects when taken over a longer period and at an earlier age," said Dr. Nicola Veronese, lead author of the Journal of the American Geriatrics Society study.


Explore further

Review links albuminuria to cognitive impairment, dementia

More information: Nicola Veronese et al, Low-Dose Aspirin Use and Cognitive Function in Older Age: A Systematic Review and Meta-analysis, Journal of the American Geriatrics Society (2017). DOI: 10.1111/jgs.14883
Provided by Wiley
Citation: Review finds no benefit to aspirin for preserving cognitive function (2017, April 20) retrieved 28 March 2020 from https://medicalxpress.com/news/2017-04-benefit-aspirin-cognitive-function.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments